Expanding access to contraceptives


Jessica Scranton/FHI 360

We continued our work to expand access to affordable, long-acting contraceptive methods by launching a new partnership in 2014 with Medicines360 and Marie Stopes International to support the initial introduction in Kenya of Medicines360’s levonorgestrel-releasing intrauterine system (LNG-IUS), which was recently approved by the U.S. Food and Drug Administration. A preliminary market assessment coordinated by FHI 360 found that the LNG-IUS product currently marketed in Kenya is prohibitively expensive for most women there. Medicines360’s product will be affordably priced to help increase access and choice. FHI 360 will provide technical assistance for a strategy that looks at factors — registration, training, demand creation and others — needed for a successful introduction of the product in Kenya.  

Funder: Reproductive Health Supplies Coalition Project: Introduction of a new LNG-IUS in Kenya through a Public–Private Partnership